Abstract:Background & aims: Temporal oscillations in intestinal nutrient processing and absorption are coordinated by the local clock, which leads to the hypothesis that the intestinal clock has major impacts on shaping peripheral rhythms via diurnal nutritional signals. Here, we investigate the role of the intestinal clock in controlling liver rhythmicity and metabolism. Methods: Transcriptomic analysis, metabolomics, metabolic assays, histology, quantitative (q)PCR, and immunoblotting were performed with Bmal1-intestine-specific knockout (iKO), Rev-erba-iKO, and control mice. Results: Bmal1 iKO caused large-scale reprogramming of the rhythmic transcriptome of mouse liver with a limited effect on its clock. In the absence of intestinal Bmal1, the liver clock was resistant to entrainment by inverted feeding and a high-fat diet. Importantly, Bmal1 iKO remodelled diurnal hepatic metabolism by shifting to gluconeogenesis from lipogenesis during the dark phase, leading to elevated glucose production (hyperglycaemia) and insulin insensitivity. Conversely, Rev-erba iKO caused a diversion to lipogenesis from gluconeogenesis during the light phase, resulting in enhanced lipogenesis and an increased susceptibility to alcohol-related liver injury. These temporal diversions were attributed to disruption of hepatic SREBP-1c rhythmicity, which was maintained via gut-derived polyunsaturated fatty acids produced by intestinal FADS1/2 under the control of a local clock. Conclusions: Our findings establish a pivotal role for the intestinal clock in dictating liver rhythmicity and diurnal metabolism, and suggest targeting intestinal rhythms as a new avenue for improving metabolic health. Impact and implications: Our findings establish the centrality of the intestinal clock among peripheral tissue clocks, and associate liver-related pathologies with its malfunction. Clock modifiers in the intestine are shown to modulate liver metabolism with improved metabolic parameters. Such knowledge will help clinicians improve the diagnosis and treatment of metabolic diseases by incorporating intestinal circadian factors.

Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein*

Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein

Circadian Clock Regulation of Hepatic Lipid Metabolism by Modulation of M6a Mrna Methylation.

Insulin Post-Transcriptionally Modulates Bmal1 Protein to Affect the Hepatic Circadian Clock

Cryptochrome Mediates Circadian Regulation of Camp Signaling and Hepatic Gluconeogenesis

BMAL1 Regulates Glucokinase Expression Through E-Box Elements In Vitro

CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1.

O-GlcNAcylation of BMAL1 regulates circadian rhythms in NIH3T3 fibroblasts.

Regulation of hepatic circadian metabolism by the E3 ubiquitin ligase HRD1-controlled CREBH/PPARα transcriptional program

Switch/Sucrose Nonfermentable (Swi/Snf) Complex Subunit Baf60a Integrates Hepatic Circadian Clock And Energy Metabolism

Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness

Cell-specific regulation of the circadian clock by BMAL1 in the paraventricular nucleus: Implications for regulation of systemic biological rhythms

Reprogramming of rhythmic liver metabolism by intestinal clock

Circadian clock controls rhythms in ketogenesis by interfering with PPARα transcriptional network

[Internal Circadian Clock and Liver Metabolism].

Circadian Metabolic Regulation Through Crosstalk Between Casein Kinase 1δ and Transcriptional Coactivator PGC-1α

Rhythmic expression of miR‐27b‐3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver

Tfeb Regulates Per3 Expression Via Glucose-Dependent Effects on Clock/Bmal1

RBP4 Functions As a Hepatokine in the Regulation of Glucose Metabolism by the Circadian Clock in Mice

Metabolic Profile and Lipid Metabolism Phenotype in Mice with Conditional Deletion of Hepatic BMAL1

Defining the mammalian coactivation of hepatic 12-h clock and lipid metabolism